EcoDrugPlus

Granzyme B-Like

Ensembl ID : ENSBSLG00000001990
Gene Symbol: LOC114854663
2 Cross references
1065 Possible Orthologues:

Granzyme-Like Protein 1

Ensembl ID : ENSBSLG00000001988
Gene Symbol: LOC114854662
2 Cross references
1019 Possible Orthologues:

Growth Hormone Releasing Hormone Receptor

Ensembl ID : ENSBSLG00000000793
Gene Symbol: GHRHR
3 Cross references
193 Possible Orthologues:

Growth Hormone Secretagogue Receptor

Ensembl ID : ENSBSLG00000013087
Gene Symbol: GHSR
3 Cross references
212 Possible Orthologues:

Guanylate Cyclase 1 Soluble Subunit Alpha 1

Ensembl ID : ENSBSLG00000000033
Gene Symbol: GUCY1A1
3 Cross references
201 Possible Orthologues:

Guanylate Cyclase 1 Soluble Subunit Alpha 2

Ensembl ID : ENSBSLG00000013816
Gene Symbol: GUCY1A2
3 Cross references
204 Possible Orthologues:

Guanylate Cyclase 1 Soluble Subunit Beta 1

Ensembl ID : ENSBSLG00000000034
Gene Symbol: GUCY1B1
3 Cross references
211 Possible Orthologues:

Heat Shock Protein 90 Alpha Family Class B Member 1

Ensembl ID : ENSBSLG00000005216
Gene Symbol: HSP90AB1
3 Cross references
355 Possible Orthologues:

Heat Shock Protein Hsp 90-Alpha 1

Ensembl ID : ENSBSLG00000019526
Gene Symbol: LOC114849323
3 Cross references
305 Possible Orthologues:

High Mobility Group Protein B1-Like

Ensembl ID : ENSBSLG00000013129
Gene Symbol: LOC114868076
3 Cross references
512 Possible Orthologues:

High Mobility Group Protein B1-Like

Ensembl ID : ENSBSLG00000007188
Gene Symbol: LOC114869232
2 Cross references
498 Possible Orthologues:

Histamine H2 Receptor-Like

Ensembl ID : ENSBSLG00000025871
Gene Symbol: LOC114869421
2 Cross references
181 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).